| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.49 | 0.006 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.007 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.007 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.077 | 0.007 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.007 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.007 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.007 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.085 | 0.008 |